NuGen Medical Devices Inc
XTSX:NGMD
Cash Flow Statement
Cash Flow Statement
NuGen Medical Devices Inc
| Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Net Income |
(4)
|
(9)
|
(9)
|
(8)
|
(8)
|
(5)
|
(2)
|
(3)
|
(2)
|
|
| Depreciation & Amortization |
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Stock-Based Compensation |
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
1
|
3
|
2
|
2
|
2
|
0
|
(3)
|
(1)
|
(2)
|
|
| Change in Working Capital |
(1)
|
(1)
|
1
|
2
|
2
|
(0)
|
(1)
|
(1)
|
(2)
|
|
| Cash from Operating Activities |
(4)
N/A
|
(7)
-73%
|
(5)
+18%
|
(3)
+42%
|
(3)
+2%
|
(5)
-51%
|
(5)
0%
|
(5)
-10%
|
(5)
-3%
|
|
| Investing Cash Flow | ||||||||||
| Capital Expenditures |
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
|
| Other Items |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Cash from Investing Activities |
0
N/A
|
(0)
N/A
|
(0)
-1%
|
(0)
-1%
|
(0)
-1%
|
(0)
+78%
|
(0)
+3%
|
(0)
-453%
|
(0)
-119%
|
|
| Financing Cash Flow | ||||||||||
| Net Issuance of Common Stock |
8
|
8
|
6
|
2
|
1
|
1
|
1
|
1
|
0
|
|
| Net Issuance of Debt |
(1)
|
(1)
|
(1)
|
(0)
|
10
|
10
|
10
|
10
|
0
|
|
| Other |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
7
N/A
|
7
0%
|
5
-23%
|
2
-62%
|
11
+415%
|
11
+3%
|
11
-6%
|
11
+0%
|
0
-96%
|
|
| Change in Cash | ||||||||||
| Effect of Foreign Exchange Rates |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Change in Cash |
3
N/A
|
0
-90%
|
(0)
N/A
|
(1)
-1 949%
|
8
N/A
|
6
-16%
|
6
-11%
|
5
-9%
|
(5)
N/A
|
|
| Free Cash Flow | ||||||||||
| Free Cash Flow |
(4)
N/A
|
(7)
-73%
|
(5)
+18%
|
(3)
+42%
|
(3)
+2%
|
(5)
-51%
|
(5)
+0%
|
(5)
-12%
|
(6)
-4%
|
|